These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Longitudinal evaluation of cognitive disorder in Huntington's disease. Snowden J; Craufurd D; Griffiths H; Thompson J; Neary D J Int Neuropsychol Soc; 2001 Jan; 7(1):33-44. PubMed ID: 11253840 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. Rozzini L; Chilovi BV; Conti M; Bertoletti E; Zanetti M; Trabucchi M; Padovani A Int Psychogeriatr; 2010 Feb; 22(1):114-9. PubMed ID: 19552831 [TBL] [Abstract][Full Text] [Related]
10. [Executive dysfunction in Huntington's disease]. Redondo Vergé L; Brown RG; Chacón J Rev Neurol; 2001 May 16-31; 32(10):923-9. PubMed ID: 11424047 [TBL] [Abstract][Full Text] [Related]
12. Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease. Smith MM; Mills JA; Epping EA; Westervelt HJ; Paulsen JS; Neuropsychology; 2012 Sep; 26(5):664-9. PubMed ID: 22846033 [TBL] [Abstract][Full Text] [Related]
13. [Huntington chorea. Clinical correlations and preliminary neuropsychological data]. Fragassi NA; Stanzione M; Angelini R; Di Maio L Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. Stout JC; Jones R; Labuschagne I; O'Regan AM; Say MJ; Dumas EM; Queller S; Justo D; Santos RD; Coleman A; Hart EP; Dürr A; Leavitt BR; Roos RA; Langbehn DR; Tabrizi SJ; Frost C J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):687-94. PubMed ID: 22566599 [TBL] [Abstract][Full Text] [Related]
15. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured? Eddy CM; Rickards HE Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931 [TBL] [Abstract][Full Text] [Related]
16. The impact of oculomotor functioning on neuropsychological performance in Huntington disease. Carvalho JO; Long JD; Westervelt HJ; Smith MM; Bruce JM; Kim JI; Mills JA; Paulsen JS; J Clin Exp Neuropsychol; 2016; 38(2):217-26. PubMed ID: 26745770 [TBL] [Abstract][Full Text] [Related]
17. Early cognitive deficits in Swedish gene carriers of Huntington's disease. Robins Wahlin TB; Lundin A; Dear K Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528 [TBL] [Abstract][Full Text] [Related]
18. The potential of composite cognitive scores for tracking progression in Huntington's disease. Jones R; Stout JC; Labuschagne I; Say M; Justo D; Coleman A; Dumas EM; Hart E; Owen G; Durr A; Leavitt BR; Roos R; O'Regan A; Langbehn D; Tabrizi SJ; Frost C J Huntingtons Dis; 2014; 3(2):197-207. PubMed ID: 25062862 [TBL] [Abstract][Full Text] [Related]
20. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study. Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]